These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
137 related articles for article (PubMed ID: 28289686)
1. Simultaneous Therapy with Intravitreal Dexamethasone Implant and Bevacizumab for the Treatment of Macular Edema. de Andrade FL; Lopes FS; de Andrade GC; Prata TS; Maia A Med Hypothesis Discov Innov Ophthalmol; 2016; 5(1):4-9. PubMed ID: 28289686 [TBL] [Abstract][Full Text] [Related]
2. Dexamethasone Intravitreal Implant Rescue Treatment for Bevacizumab Refractory Macular Edema Secondary to Branch Retinal Vein Occlusion. Lee KH; Kang EC; Koh HJ Korean J Ophthalmol; 2017 Apr; 31(2):108-114. PubMed ID: 28367038 [TBL] [Abstract][Full Text] [Related]
3. Use of intravitreal dexamethasone implant in patients with cataract and macular edema undergoing phacoemulsification. Sze AM; Luk FO; Yip TP; Lee GK; Chan CK Eur J Ophthalmol; 2015; 25(2):168-72. PubMed ID: 25363857 [TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of dexamethasone intravitreal implant in patients with retinal vein occlusion resistant to anti-VEGF therapy: a 12-month prospective study. Georgalas L; Tservakis I; Kiskira EE; Petrou P; Papaconstantinou D; Kanakis M Cutan Ocul Toxicol; 2019 Dec; 38(4):330-337. PubMed ID: 31060385 [No Abstract] [Full Text] [Related]
6. Prospective evaluation of morphological and functional changes after repeated intravitreal dexamethasone implant (Ozurdex®) for retinal vein occlusion. Bandello F; Parravano M; Cavallero E; Cascavilla ML; Triolo G; Querques L; Borrelli E; Giorno P; Varano M; Lattanzio R; Querques G Ophthalmic Res; 2015; 53(4):207-16. PubMed ID: 25896233 [TBL] [Abstract][Full Text] [Related]
7. SD-OCT pattern of retinal venous occlusion with cystoid macular edema treated with Ozurdex®. Coscas G; Coscas F; Zucchiatti I; Glacet-Bernard A; Soubrane G; Souïed E Eur J Ophthalmol; 2011; 21(5):631-6. PubMed ID: 21500185 [TBL] [Abstract][Full Text] [Related]
8. Bevacizumab versus Dexamethasone Implant Followed by Bevacizumab for the Treatment of Macula Edema Associated with Branch Retinal Vein Occlusion. Moon SY; Cho KH; Woo SJ; Park SP; Kim YK Korean J Ophthalmol; 2018 Feb; 32(1):29-37. PubMed ID: 29376223 [TBL] [Abstract][Full Text] [Related]
9. Combination of Intravitreal Corticosteroid with Anti-vegf in Macular Edema Secondary to Retinal Vein Occlusion. Valašková J; Popov I; Krásnik V Cesk Slov Oftalmol; 2018; 73(5-6):183-188. PubMed ID: 30541298 [TBL] [Abstract][Full Text] [Related]
10. Effect of combination therapy with bevacizumab and dexamethasone intravitreal implant in patients with retinal vein occlusion. Singer MA; Bell DJ; Woods P; Pollard J; Boord T; Herro A; Porbandarwalla S Retina; 2012 Jul; 32(7):1289-94. PubMed ID: 22466480 [TBL] [Abstract][Full Text] [Related]
11. EFFICACY AND FREQUENCY OF INTRAVITREAL AFLIBERCEPT VERSUS BEVACIZUMAB FOR MACULAR EDEMA SECONDARY TO CENTRAL RETINAL VEIN OCCLUSION. Lotfy A; Solaiman KAM; Abdelrahman A; Samir A Retina; 2018 Sep; 38(9):1795-1800. PubMed ID: 28767552 [TBL] [Abstract][Full Text] [Related]
12. Intravitreal bevacizumab (avastin) for central and hemicentral retinal vein occlusions: IBeVO study. Costa RA; Jorge R; Calucci D; Melo LA; Cardillo JA; Scott IU Retina; 2007 Feb; 27(2):141-9. PubMed ID: 17290194 [TBL] [Abstract][Full Text] [Related]
13. Bevacizumab compared with macular laser grid photocoagulation for cystoid macular edema in branch retinal vein occlusion. Russo V; Barone A; Conte E; Prascina F; Stella A; Noci ND Retina; 2009 Apr; 29(4):511-5. PubMed ID: 19174717 [TBL] [Abstract][Full Text] [Related]
14. Short-Term Assessment of Intravitreal Dexamethasone Implant Using Enhanced-Depth Image Optical Coherence Tomography and Optical Coherence Tomography Angiography in Patients with Retinal Vascular Diseases. Minnella AM; Federici M; Pagliei V; Lanza A; Gambini G; Caputo CG; Falsini B; Caporossi A Adv Ther; 2019 Feb; 36(2):416-425. PubMed ID: 30565180 [TBL] [Abstract][Full Text] [Related]
15. Intravitreal bevacizumab (Avastin) treatment of macular edema in central retinal vein occlusion: a short-term study. Iturralde D; Spaide RF; Meyerle CB; Klancnik JM; Yannuzzi LA; Fisher YL; Sorenson J; Slakter JS; Freund KB; Cooney M; Fine HF Retina; 2006 Mar; 26(3):279-84. PubMed ID: 16508427 [TBL] [Abstract][Full Text] [Related]
16. Intravitreal Dexamethasone Implant for the Treatment of Postoperative Macular Edema. Klamann A; Böttcher K; Ackermann P; Geerling G; Schargus M; Guthoff R Ophthalmologica; 2016; 236(4):181-185. PubMed ID: 27915343 [TBL] [Abstract][Full Text] [Related]
17. Short-term safety of dexamethasone implant for treatment of macular edema due to retinal vein occlusion, in eyes with glaucoma or treated ocular hypertension. Theodoropoulou S; Ellabban AA; Johnston RL; Cilliers H; Mohamed Q; Sallam AB Graefes Arch Clin Exp Ophthalmol; 2017 Apr; 255(4):725-732. PubMed ID: 27878430 [TBL] [Abstract][Full Text] [Related]
18. Comparison of two doses of intravitreal bevacizumab as primary treatment for macular edema secondary to central retinal vein occlusion: results of the pan American collaborative retina study group at 24 months. Wu L; Arevalo JF; Berrocal MH; Maia M; Roca JA; Morales-Cantón V; Alezzandrini AA; Díaz-Llopis MJ Retina; 2010; 30(7):1002-11. PubMed ID: 20616679 [TBL] [Abstract][Full Text] [Related]
19. Two or more dexamethasone intravitreal implants in treatment-naïve patients with macular edema due to retinal vein occlusion: subgroup analysis of a retrospective chart review study. Dugel PU; Capone A; Singer MA; Dreyer RF; Dodwell DG; Roth DB; Shi R; Walt JG; Scott LC; Hollander DA; BMC Ophthalmol; 2015 Sep; 15():118. PubMed ID: 26337664 [TBL] [Abstract][Full Text] [Related]
20. Ranibizumab versus Dexamethasone Implant in Macular Edema Secondary to Branch Retinal Vein Occlusion: Two-year Outcomes. Ozkaya A; Tarakcioglu HN; Tanir I Optom Vis Sci; 2018 Dec; 95(12):1149-1154. PubMed ID: 30451802 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]